Prothena Corp. Plc (PRTA)
9.56
-0.05
(-0.52%)
USD |
NASDAQ |
Sep 02, 12:42
Prothena Cash from Operations (Annual) : -163.58M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -163.58M |
| December 31, 2024 | -150.05M |
| December 31, 2023 | -133.91M |
| December 31, 2022 | -108.82M |
| December 31, 2021 | 92.60M |
| December 31, 2020 | -80.36M |
| December 31, 2019 | -52.97M |
| December 31, 2018 | -28.28M |
| Date | Value |
|---|---|
| December 31, 2017 | -131.18M |
| December 31, 2016 | -117.27M |
| December 31, 2015 | -62.46M |
| December 31, 2014 | -0.683M |
| December 31, 2013 | -32.10M |
| December 31, 2012 | -42.07M |
| December 31, 2011 | -19.70M |
| December 31, 2010 | -9.10M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Alkermes Plc | 520.75M |
| Amarin Corp. Plc | 6.744M |
| Agenus, Inc. | -77.20M |
| Amgen, Inc. | 9.958B |
| Anika Therapeutics, Inc. | 11.19M |